How many employees does Dianthus Therapeutics, Inc. have?

Dianthus Therapeutics, Inc. reported 92 employees for the fiscal year ending Dec 2025, in the annual report it filed on March 9, 2026. That is up 17.9% from a year earlier.

What is Dianthus Therapeutics, Inc.'s revenue per employee?

Dianthus Therapeutics, Inc. brought in $2.0M of revenue in fiscal Dec 2025, which is $22K per employee. That ranks 45 of 46 companies we track in Biotechnology, where the median is $574K.

Where do these numbers come from?

Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Company data

Dianthus Therapeutics, Inc. employees and revenue per employee

DNTH · Biotechnology · $4.61B market cap

Dianthus Therapeutics, Inc. had 92 employees at the end of fiscal Dec 2025, up 17.9% from a year earlier. Revenue for the year was $2.0M, down 67.3% from a year earlier, or $22K per employee. Revenue fell while headcount grew.

Employees

+17.9% YoY

Revenue

$2.0M

-67.3% YoY

Revenue / employee

$22K

Peer median $574K

Rank in industry

45 of 46

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2023

Hover a year for the numbers.

DNTH employees and revenue by fiscal year
Year ending	Employees	Revenue	Per employee	Staff YoY	Revenue YoY
Dec 2025	92	$2.0M	$22K	+17.9%	-67.3%
Dec 2024	78	$6.2M	$80K	+47.2%	+120.6%
Dec 2023	53	$2.8M	$53K	—	—

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years

Revenue per employee, last six fiscal years

Dianthus Therapeutics, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

Company	Employees	Revenue	Revenue / employee	Shape
PTGX Protagonist Therapeutics, Inc.	132	$46.0M	$349K	Hiring into decline
KYMR Kymera Therapeutics, Inc.	238	$39.2M	$165K	Hiring into decline
RLAY Relay Therapeutics, Inc.	192	$15.4M	$80K	Leaner
PRAX Praxis Precision Medicines, Inc.	116	$8.6M	$74K	Efficient growth
PGEN Precigen, Inc.	160	$9.7M	$61K	Efficient growth
IMNM Immunome, Inc.	177	$6.9M	$39K	Hiring into decline
CGON CG Oncology Inc.	142	$4.0M	$28K	Efficient growth
DNTH Dianthus Therapeutics, Inc.	92	$2.0M	$22K	Hiring into decline
CRNX Crinetics Pharmaceuticals, Inc.	594	$7.7M	$13K	Efficient growth

Every Healthcare company

Questions about Dianthus Therapeutics, Inc.

How many employees does Dianthus Therapeutics, Inc. have?: Dianthus Therapeutics, Inc. reported 92 employees for the fiscal year ending Dec 2025, in the annual report it filed on March 9, 2026. That is up 17.9% from a year earlier.
What is Dianthus Therapeutics, Inc.'s revenue per employee?: Dianthus Therapeutics, Inc. brought in $2.0M of revenue in fiscal Dec 2025, which is $22K per employee. That ranks 45 of 46 companies we track in Biotechnology, where the median is $574K.
Where do these numbers come from?: Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Free game

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

More data

Compare DNTH with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Leaderboard Healthcare

Source: employee counts and revenue as stated in Dianthus Therapeutics, Inc.'s annual reports (Form 10-K), latest filed March 9, 2026. This is data, not a recommendation to buy or sell DNTH.